Home
About
Overview
Sharing Data
ORCID
Help
History (16)
A clinical trial of a microcrystalline cellulose topical nasal spray on the acute response to allergen challenge.
Cytochrome P-450 CYP2C8 Inhibitors
Sequestering Agents
Principal Investigator
Methyltransferase Inhibition Enables Tgfß Driven Induction of CDKN2A and B in Cancer Cells.
See All 16 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Methyltransferase Inhibition Enables Tgfß Driven Induction of CDKN2A and B in Cancer Cells.
Methyltransferase Inhibition Enables Tgfß Driven Induction of CDKN2A and B in Cancer Cells. Mol Cell Biol. 2023; 43(3):115-129.
View in:
PubMed
subject areas
Cell Line, Tumor
Cyclin-Dependent Kinase Inhibitor p15
Cyclin-Dependent Kinase Inhibitor p16
HeLa Cells
Humans
Methyltransferases
Neoplasms
Transforming Growth Factor beta
authors with profiles
Mark Applebaum